Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 8/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.65 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.65 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.65 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.65 |
| ▸ | PGR | P06401 | 1/20 | 0.65 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.65 |
| ▸ | RXRA | P19793 | 1/20 | 0.65 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.65 |
| ▸ | CCKAR | P32238 | 1/20 | 0.65 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.65 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.65 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.65 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.65 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4906087 | 1.00 | HMGCR (0.65) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL4906083 | 1.00 | HMGCR (0.65) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL29723144 | 1.00 | HMGCR (0.65) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL4906075 | 1.00 | HMGCR (0.65) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL5688703 | 0.91 | CYP2C9 (0.69) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL5688708 | 0.91 | CYP2C9 (0.69) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL4905705 | 0.88 | HMGCR (0.79) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL557747 | 0.88 | HMGCR (0.79) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL557534 | 0.88 | HMGCR (0.79) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL4905717 | 0.88 | HMGCR (0.79) | HMGCRCYP2C9SIRT6ABCC3ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120035374-A1 | PROCESS FOR THE PREPARATION OF FLUVASTATIN AND SALTS THEREOF | PHARMATHEN S.A. (GR) | 2012-02-09 | — | — | US | disclosed |
| US-7662848-B2 | Process for the preparation of Fluvastatin Sodium salt | F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. (IT) | 2010-02-16 | — | — | US | disclosed |
| US-7662848-B2 | Process for the preparation of Fluvastatin Sodium salt | F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. (IT) | 2010-02-16 | — | — | US | disclosed |
| US-20070249704-A1 | Process for the preparation of fluvastatin sodium salt | F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. (IT) | 2007-10-25 | — | — | US | disclosed |
| US-20070249704-A1 | Process for the preparation of fluvastatin sodium salt | F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. (IT) | 2007-10-25 | — | — | US | disclosed |
| US-20040176614-A1 | Process for the preparation of indole derivatives and intermediates of the process | WOLLEB ANNEMARIE (CH) | 2004-09-09 | — | — | US | disclosed |
| US-6743926-B2 | FORMING SUCH AS 5-(3-(4-FLUOROPHENYL)-1-ISOPROPYL-1H-INDOL-2-YL)-3,5-DIHYDROXYPENT-2-ENOIC ACID METHYL ESTER | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-06-01 | — | — | US | disclosed |
| US-20030166946-A1 | Process for the preparation of indole derivatives and intermediates of the process | CIBA SPECIALTY CHEMICALS CORP. | 2003-09-04 | — | — | US | disclosed |
| EP-1284964-A1 | PROCESS FOR THE PREPARATION OF INDOLE DERIVATIVES AND INTERMEDIATES OF THE PROCESS | Ciba SC Holding AG (CH) | 2003-02-26 | — | — | EP | disclosed |
| WO-2001092223-A1 | PROCESS FOR THE PREPARATION OF INDOLE DERIVATIVES AND INTERMEDIATES OF THE PROCESS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-12-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249704-A1 | Process for the preparation of fluvastatin sodium salt | HMGCR, HSD11B1, CYP11A1 | HMGCR 1/4885CYP2C9 131/4885SIRT6 2524/4885 |
| US-20030166946-A1 | Process for the preparation of indole derivatives and intermediates of the process | TPH1, IDO1, TDO2 | HMGCR 606/4885CYP2C9 116/4885SIRT6 1105/4885 |
| US-20120035374-A1 | PROCESS FOR THE PREPARATION OF FLUVASTATIN AND SALTS THEREOF | HMGCR, CETP, PCSK9 | HMGCR 1/4885CYP2C9 61/4885SIRT6 1760/4885 |
| US-20040176614-A1 | Process for the preparation of indole derivatives and intermediates of the process | TPH1, HTR4, TPH2 | HMGCR 612/4885CYP2C9 115/4885SIRT6 1064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.